Abstract
We are in the midst of the UN Decade of Ocean Science for Sustainable Development (2021–30), which provides a timely opportunity for the epidemiological community to assess the global burden of thalassogenic diseases such as paralytic shellfish poisoning (PSP). In this epidemiological review, we used systematic search tools to summarise 152 peer-reviewed articles describing human PSP cases. Our analysis revealed that PSP cases have been reported from every inhabited continent; symptoms reported by patients might differ by continent; and exposure sources are not limited to the eponymic shellfish. Furthermore, most cases described lacked demographic details that could aid in a more comprehensive understanding of PSP epidemiology. Overall, this Review highlights PSP as a true global health concern; however, the overall poor quality of available data underscores the need for greater epidemiological attention as an understudied global health challenge.
Introduction
We are in the midst of the UN Decade of Ocean Science for Sustainable Development (2021–30), a period designated by the UN as especially timely for advancing research efforts towards achieving a safe ocean where life and livelihoods are protected from ocean-related hazards.1 This decade presents a crucial opportunity for the public health research community to contribute to transdisciplinary dialogues on the intersection of oceans and human health.2 Within this framework, seafood is a crucial contributor to shaping nutrition and economies globally.3 However, chemical contaminants present in seafood pose considerable health risks that might counterbalance its potential nutritional benefits.4
Fisheries economists often focus on the economic consequences of harmful algal blooms (HABs), particularly those arising from commercial fishery closures intended to prevent human exposure to marine toxins.5 However, economic losses also stem from the persistent disease burden caused by HAB toxins despite preventive measures—eg, poisoning from toxins in non-monitored seafood, such as subsistence harvests.6 Since the incidence of HAB-related poisonings is increasingly linked to climate change, the associated health costs have implications for broader policy debates around the social cost of carbon that epidemiologists actively contribute to.7 Although regional reviews of paralytic shellfish poisoning (PSP) epidemiology exist—covering areas such as Alaska,8 Japan,9 Portugal,10 South Africa,11 Tasmania,12 and Venezuela13—a comprehensive synthesis of evidence of the global burden of PSP remains necessary.
The urgency for public health scientists to investigate the health effects of HABs has grown as climate change intensifies environmental uncertainties, and the number of reports of HAB events appears to be increasing, at least in the USA.14,15 PSP, caused by some HAB species such as Alexandrium,16 remains a crucial concern. However, substantial gaps persist in understanding how climate change influences the environmental risk factors for PSP, including the genetic, physiological, and ecological responses of harmful algae.17 Evidence suggests that climate change affects the growth conditions of marine harmful algae,18 including PSP-related taxa such as Alexandrium.19 Additionally, climate change and ocean acidification might alter the toxicokinetics of shellfish and the bioavailability of PSP toxins, thereby influencing human exposure.20,21 Given this evolving environmental risk landscape, a thorough review of the global epidemiology of PSP is essential.
Beyond the relevance of this Review to ocean-related health hazards, we also address a growing theme in neurology: the role of environmental risk factors in the global burden of neurological disorders.22 Although the global prevalence of common neurological diseases has risen over recent decades,23,24 temporal trends in neurological toxidromes such as PSP remain poorly understood. Some localised studies have examined PSP, such as an assessment of cases reported in British Columbia from 1941 to 2020.25 Yet, there is considerable value in updating and consolidating PSP data on a global scale to facilitate broader spatiotemporal trends.
The primary objective of this epidemiological literature review was to characterise the spatiotemporal distribution and population burden of PSP documented in peer-reviewed scientific publications. The secondary goal of this Review was to delineate PSP risk factors and clinical presentations.
Methods
The review protocol was registered with PROSPERO as an epidemiological review (CRD42022376906). This Review was conducted in accordance with the PRISMA reporting guidelines.
Search strategy and selection criteria
PubMed, Embase, Scopus, and Web of Science databases were searched on Aug 8, 2022, with updated searches on Feb 20, 2023, and March 26, 2024. The search strategy is detailed in the panel. The search strategy was designed to comprehensively identify epidemiological reports of PSP while enhancing the specificity of our search by excluding articles on toxic exposures unrelated to algal toxins that cause PSP (eg, mercury, arsenic, and pesticides) and non-human research.
This Review included all articles describing outcomes related to PSP, such as case reports or epidemiological literature, published in peer-reviewed journals, irrespective of language. Both primary research articles and review papers documenting specific instances of PSP in human populations were considered eligible. Articles focusing exclusively on non-human data—such as toxin concentrations in shellfish without reference to human cases or the presence of algal species without associated human poisoning—were excluded. Reports not published in peer-reviewed journals were also excluded.
Selection process and data collection process
Each article was screened by two independent reviewers at both the title and abstract screening and full-text screening stages. Disagreements about article eligibility between reviewers were handled using post-hoc tie-breaking decisions after re-examination of the article, involving either consensus between the initial reviewers or the input of a third reviewer. Data extraction was likewise conducted independently by two reviewers per article, with any disagreements addressed using the post-hoc tie-breaking decision. Article screening, data abstraction, and tiebreaking decisions were conducted using Covidence Systematic Review Software (Veritas Health Innovation, Melbourne, Australia). Non-English articles were evaluated by study team members or collaborators fluent in the respective languages according to the same procedure as described for screening English articles. One Korean-language article identified as potentially relevant by a colleague was translated into English by LanguageLine Solutions (Monterey, California);26 all other non-English articles were evaluated in their original language.
Data extraction and risk of bias assessment
The following data were extracted from each included article, as available and applicable: article title, surname of the first author, year of publication, journal name, affiliations of all authors (eg, institution and department), source of funding or sponsorship (eg, governmental, non-governmental, unsponsored, or not reported), article language, number of outbreaks reported, study design (eg, ecological/time-series/surveillance, case series, or other), definition of PSP cases, and demographic characteristics of affected individuals. PSP case definitions were categorised as follows: definite—symptoms attributed to PSP following seafood consumption with saxitoxin biomarker confirmation (in human urine or seafood consumed); probable—symptoms attributed to PSP following seafood consumption without biomarker confirmation; possible—symptoms described as potentially consistent with PSP after seafood consumption without biomarker confirmation; and not specified—typically observed in surveillance summaries reporting aggregate PSP case counts. Additionally, the following data were extracted for each outbreak: number of cases, start and end dates, symptom duration, number of hospitalised cases, number of cases requiring intensive care, duration of hospitalisation, number of deaths, time to death (per fatal case), geographical location, reported symptoms, time to earliest symptom onset (categorised as <30 min, 1–4 h, >4 to 12 h, ≥12 h, or not reported), and identified risk factors or exposures (eg, molluscs or shellfish, fish, algae or water, or unspecified). Further details included the specific exposure source, toxigenic algae involved, location of exposure (eg, home, vacation or tourist setting, or not reported), source of seafood (eg, personal fishing, clamming, or subsistence harvesting, purchased at a market or store, consumed in a restaurant or catered event, or not reported), and whether the study specified a target population to which the findings could be generalised. Data not included in articles were recorded as not reported.27
Given the heterogeneity of the included studies, an overall assessment of evidence quality was undertaken based on both reported data and a risk of bias evaluation. Although our PROSPERO-registered protocol (CRD42022376906), submitted as an “epidemiologic review” in PROSPERO), initially specified a risk of bias assessment adapted from the Risk Of Bias In Non-Randomised Studies of Interventions (ROBINS-I)28 and the Newcastle-Ottawa Scale,29 most of the included articles were case reports or case series. Therefore, we used a modified version of the Grading of Recommendations Assessment, Development and Evaluation (GRADE) framework to evaluate the risk of bias,30 which was assessed for each article based on the following indicators: author affiliations (institution and department), source of funding or sponsorship, study design, PSP case definition used, and whether the article defined a target population for generalisability. Two independent reviewers assessed each article against the criteria, with any discrepancies resolved through consensus or, if necessary, adjudication by a third reviewer.
Effect measures and synthesis methods
Most articles included in this Review (eg, case reports and case series) were inadequate for quantitative estimates; therefore, a meta-analysis could not be performed. In lieu of effect measures, we summarised the findings of individual articles descriptively, including the use of contingency tables to illustrate relationships between variables such as the type of seafood consumed and symptoms reported.
Results
Literature review
The figure presents the flow diagram for article selection. The literature search yielded 7335 articles. After excluding 148 duplicate articles, titles and articles of 7188 articles were screened. 6837 articles were excluded, and 350 full-text articles were assessed for eligibility. Among the 350 full-text articles, one full-text article could not be retrieved,31 180 were excluded for not reporting PSP outcomes in humans, and 17 were excluded for being non-peer-reviewed publications, resulting in 152 articles being finally included in the evaluation.6,8–13,15,25,26,32–173
Figure:

Flow diagram of study screening and selection for a review of global PSP outbreaks.
Results of individual articles
Key features of the individual articles are summarised in tables 1–3.
Table 1:
Case demographics
| Age range |
Race or ethnicity |
Sex |
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0–9 | 10–19 | 20–29 | 30–39 | 40–49 | 50–59 | 60–69 | 70–79 | ≥80 | Not reported | White | Black | Hispanic | Native or indigenous | Asian | Other* | Not reported | Female | Male | Not reported | |
| Africa | ||||||||||||||||||||
| McFarren et al (1960)109 | X | >100 | X | |||||||||||||||||
| Popkiss et al (1979)11 | X | 17 | 0 | 0 | 0 | 0 | 0 | 7 | 10 | |||||||||||
| Batoréu et al (2005)46 | X | X | X | |||||||||||||||||
| Arnich and Thébault (2018)35 | X | X | X | X | X | X | X | X | 6 | 10 | ||||||||||
| Marks et al (2019)105 | X | X | X | |||||||||||||||||
| Vale (2020)166 | X | X | X | |||||||||||||||||
| Asia | ||||||||||||||||||||
| Kawabata et al (1962)96 | X | X | X | |||||||||||||||||
| Roy (1977)132 | X | X | 5 | 4 | ||||||||||||||||
| Imbert et al (1979)91 | X | X | X | |||||||||||||||||
| Gacutan et al (1985)73 | X | X | X | |||||||||||||||||
| Kan et al (1986)94 | X | X | X | X | >3 | >2 | ||||||||||||||
| Kim et al (1986)26 | X | X | X | X | X | 0 | 25 | |||||||||||||
| Hashimoto and Noguchi (1989)83 | X | X | X | |||||||||||||||||
| MacLean (1989)102 | X | X | X | |||||||||||||||||
| Swaddiwudhipong et al (1989)145 | X | X | X | |||||||||||||||||
| Cheng et al (1991)58 | X | X | 2 | 3 | ||||||||||||||||
| Viviani (1992)169 | X | X | X | |||||||||||||||||
| Negoro et al (1993)122 | X | X | X | X | X | X | 1 | 4 | ||||||||||||
| Hartigan-Go and Bateman (1994)82 | X | X | X | X | X | X | X | X | X | X | ||||||||||
| Todd (1994)152 | X | X | X | |||||||||||||||||
| Corrales and Maclean (1995)65 | X | X | X | |||||||||||||||||
| Hwang et al (1995)90 | X | X | X | |||||||||||||||||
| Akaeda et al (1998)9 | X | X | X | |||||||||||||||||
| Trevino (1998)162 | X | X | X | |||||||||||||||||
| Bankoff (1999)42 | X | X | X | |||||||||||||||||
| Morris (1999)118 | X | X | X | |||||||||||||||||
| Murakami and Noguchi (2000)121 | X | X | X | |||||||||||||||||
| Azanza and Taylor (2001)38 | X | X | X | |||||||||||||||||
| Bajarias et al (2002)40 | X | X | X | |||||||||||||||||
| Holmes and Teo (2002)87 | X | X | X | |||||||||||||||||
| Batoréu et al (2005)46 | X | X | X | |||||||||||||||||
| Azanza (2006)37 | X | X | X | |||||||||||||||||
| Chung et al (2006)60 | X | X | X | X | X | X | X | X | X | 32 | 26 | |||||||||
| Jen et al (2008)93 | X | X | X | |||||||||||||||||
| James et al (2010)92 | X | X | X | |||||||||||||||||
| Toda et al (2012)150 | X | X | X | |||||||||||||||||
| Ching et al (2015)59 | X | X | X | X | X | X | X | X | 13 | 18 | ||||||||||
| Suleiman et al (2017)143 | X | X | X | X | X | X | X | X | 34 | 24 | ||||||||||
| Arnich and Thébault (2018)35 | X | X | X | X | X | X | X | X | X | |||||||||||
| Azzeri et al (2020)39 | X | X | X | |||||||||||||||||
| Velayudhan et al (2021)168 | X | X | X | X | X | X | X | X | X | 116 | 103 | |||||||||
| Chen et al (2023)57 | X | X | 55 | 26 | 29 | |||||||||||||||
| Yu et al (2023)171 | X | X | X | |||||||||||||||||
| Zheng et al (2023)172 | X | X | X | X | 2 | 1 | ||||||||||||||
| McFarren et al (1960)109 | X | >100 | X | |||||||||||||||||
| McCollum et a (1968)108 | X | X | X | |||||||||||||||||
| Ayres et al (1975)36 | X | X | X | |||||||||||||||||
| Blanc et al (1977)50 | X | X | X | |||||||||||||||||
| Zwahlen et al (1977)173 | X | X | X | |||||||||||||||||
| Blanc et al (1978)51 | X | X | X | |||||||||||||||||
| Caroli et al (1978)55 | X | X | X | X | X | X | X | X | 12 | 14 | ||||||||||
| Imbert et al (1979)91 | X | X | X | |||||||||||||||||
| Gulbrandsen et al (1981)81 | X | X | 4 | 0 | 0 | 0 | 0 | 0 | 2 | 2 | ||||||||||
| Tangen (1983)146 | X | X | X | |||||||||||||||||
| Hasselgård and Hjelle (1984)84 | X | X | X | X | X | X | X | 6 | 4 | |||||||||||
| Langeland et al (1984)98 | X | X | X | X | X | X | 4 | 4 | ||||||||||||
| Sanders (1987)135 | X | X | X | |||||||||||||||||
| Mills and Passmore (1988)114 | X | X | X | |||||||||||||||||
| No authors listed (1988)124 | X | X | X | X | ||||||||||||||||
| The PHLS Communicable Disease Surveillance Centre (1990)149 | X | X | X | |||||||||||||||||
| Scoging (1991)137 | X | X | X | |||||||||||||||||
| Viviani (1992)169 | X | X | X | |||||||||||||||||
| Ledoux and Frémy (1994)99 | X | X | X | |||||||||||||||||
| Martin et al (1996)106 | X | X | X | |||||||||||||||||
| de Carvalho et al (1998)10 | X | X | X | X | X | X | X | 6 | 3 | |||||||||||
| Scoging (1998)138 | X | X | X | |||||||||||||||||
| Krys and Frémy (2002)97 | X | X | X | |||||||||||||||||
| Batoréu et al (2005)46 | X | X | X | |||||||||||||||||
| Mira Gutiérrez (2005)115 | X | X | X | |||||||||||||||||
| Rapala et al (2005)127 | X | X | X | X | ||||||||||||||||
| James et al (2010)92 | X | X | X | |||||||||||||||||
| Hinder et al (2011)86 | X | X | X | |||||||||||||||||
| Arnich and Thébault (2018)35 | X | X | X | X | X | X | X | X | 5 | 5 | ||||||||||
| Carvalho et al (2019)56 | X | X | 1 | 1 | ||||||||||||||||
| Vale (2020)166 | X | X | 1 | 2 | ||||||||||||||||
| Karlson et al (2021)95 | X | X | X | |||||||||||||||||
| Sinno-Tellier et al (2022)140 | X | X | X | X | X | X | X | 7 | 8 | |||||||||||
| Rodríguez et al (2024)131 | X | X | X | |||||||||||||||||
| North America | ||||||||||||||||||||
| Scobey (1947)136 | X | X | X | |||||||||||||||||
| Meyers and Hilliard (1955)113 | X | X | 0 | 1 | ||||||||||||||||
| Tennant et al (1955)148 | X | X | X | X | X | 5 | 2 | |||||||||||||
| Bond and Medcof (1958)52 | X | X | X | X | X | X | X | 15 | 18 | |||||||||||
| McFarren et al (1960)109 | X | >100 | 0 | >100 | ||||||||||||||||
| Meinke and Quinn (1973)112 | X | X | 0 | 1 | ||||||||||||||||
| Fortuine (1975)71 | X | X | X | |||||||||||||||||
| Cladouhos (1977)61 | X | X | 1 | 1 | ||||||||||||||||
| Craun (1977)67 | X | X | X | |||||||||||||||||
| Hughes et al (1977)88 | X | X | X | |||||||||||||||||
| Morse (1977)119 | X | X | X | |||||||||||||||||
| Todd (1977)154 | X | X | X | |||||||||||||||||
| Acres and Gray (1978)32 | X | X | 0 | 2 | ||||||||||||||||
| Imbert et al (1979)91 | X | X | X | |||||||||||||||||
| Bryan (1980)53 | X | X | X | |||||||||||||||||
| Grimard and Lalonde (1981)80 | X | X | X | 1 | 1 | |||||||||||||||
| Todd (1982)155 | X | X | X | |||||||||||||||||
| de la Garza Aguilar (1983)68 | X | X | X | X | X | X | 7 | 12 | ||||||||||||
| No authors listed (1983)123 | X | X | X | |||||||||||||||||
| Conte (1984)64 | X | X | X | |||||||||||||||||
| Todd (1985)156 | X | X | X | |||||||||||||||||
| Todd (1985)157 | X | X | X | |||||||||||||||||
| Mee et al (1986)111 | X | X | X | X | 5 | 13 | ||||||||||||||
| Sanders (1987)135 | X | X | X | |||||||||||||||||
| Todd (1987)158 | X | X | X | |||||||||||||||||
| Mills and Passmore (1988)114 | X | X | X | |||||||||||||||||
| No authors listed (1988)124 | X | X | X | X | ||||||||||||||||
| Todd (1988)159 | X | X | X | |||||||||||||||||
| Todd (1989)160 | X | X | X | |||||||||||||||||
| Long et al (1990)101 | X | X | 1 | 0 | ||||||||||||||||
| Mata et al (1990)107 | X | X | X | X | ||||||||||||||||
| No authors listed (1990)125 | X | X | X | |||||||||||||||||
| Rodrigue et al (1990)130 | X | X | X | 99 | 88 | |||||||||||||||
| Ahmed (1991)33 | X | X | X | |||||||||||||||||
| No authors listed (1991)126 | X | X | X | X | 0 | 6 | ||||||||||||||
| Saldate Castañeda et al (1991)134 | X | X | X | |||||||||||||||||
| Saldate Castañeda et al (1991)134 | X | X | X | |||||||||||||||||
| United States Centers for Disease Control and Prevention (1991)164 | X | X | X | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 6 | |||||||||
| Ahmed (1992)34 | X | X | X | |||||||||||||||||
| Viviani (1992)169 | X | X | ||||||||||||||||||
| Moss (1993)120 | X | 135 | 0 | 135 | ||||||||||||||||
| Saavedra-Deigado and Metcalfe (1993)133 | X | X | X | |||||||||||||||||
| Todd et al (1993)151 | X | X | X | 0 | 2 | |||||||||||||||
| Cortés-Altamirano et al (1995)66 | X | X | X | |||||||||||||||||
| Gessner and Middaugh (1995)77 | X | X | X | X | X | X | X | X | 37 | 0 | 0 | 33 | 12 | 0 | 44 | 66 | ||||
| Bean et al (1996)48 | X | X | X | |||||||||||||||||
| Gessner and Schloss (1996)78 | X | 0 | 0 | 0 | 12 | 0 | 1* | X | 8 | 5 | ||||||||||
| Bean et al (1997)47 | X | X | X | |||||||||||||||||
| Gessner et al (1997)8 | X | X | X | X | X | 0 | 0 | 2 | 2 | 7 | 0 | 6 | 5 | |||||||
| Gessner et al (1997)76 | X | 1 | 0 | 1 | ||||||||||||||||
| Todd (1997)153 | X | X | X | |||||||||||||||||
| Sierra-Beltrán et al (1998)139 | X | X | X | |||||||||||||||||
| Trevino (1998)162 | X | X | X | |||||||||||||||||
| Bankoff (1999)42 | X | X | X | |||||||||||||||||
| Morris (1999)118 | X | X | X | |||||||||||||||||
| United States Centers for Disease Control and Prevention (2002)165 | X | X | X | X | X | X | 1 | 4 | ||||||||||||
| United States Centers for Disease Control and Prevention (2002)165 | X | X | X | |||||||||||||||||
| Balmer-Hanchey et al (2003)41 | X | X | X | |||||||||||||||||
| Barbier and Diaz (2006)43 | X | X | X | |||||||||||||||||
| Batoréu et al (2005)46 | X | X | X | |||||||||||||||||
| Sobel and Painter (2005)142 | X | X | X | |||||||||||||||||
| Fortuine (2007)72 | X | 0 | 0 | 0 | 1+ | 0 | 0 | 0 | 1+ | |||||||||||
| Wang (2008)170 | X | X | X | |||||||||||||||||
| Barraza (2009)44 | X | X | X | 4 | 0 | |||||||||||||||
| James et al (2010)92 | X | X | X | |||||||||||||||||
| Bienfang et al (2011)49 | X | X | X | |||||||||||||||||
| McLaughlin et al (2011)110 | X | X | X | |||||||||||||||||
| Gould et al (2013)79 | X | X | X | |||||||||||||||||
| DeGrasse et al (2014)69 | X | X | X | |||||||||||||||||
| Hurley et al (2014)89 | X | X | X | X | X | 3 | 4 | |||||||||||||
| Trainer et al (2014)161 | X | X | X | |||||||||||||||||
| Callejas et al (2015)54 | X | X | X | |||||||||||||||||
| Clemence and Guerrant (2015)62 | X | X | X | |||||||||||||||||
| Knaack et al (2016)6 | X | X | X | X | X | X | X | |||||||||||||
| Arnich and Thébault (2018)35 | X | X | X | X | X | X | X | X | 30 | 48 | ||||||||||
| Coleman et al (2018)63 | X | X | 1 | 0 | ||||||||||||||||
| Anderson et al (2021)15 | X | X | X | |||||||||||||||||
| McIntyre et al (2021)25 | X | X | X | X | X | X | X | X | X | 0 | 0 | 0 | 27 | 0 | 84 | X | 48 | 63 | ||
| Sunesen et al (2021)144 | X | X | X | |||||||||||||||||
| Temple and Hughes (2022)147 | X | X | 1 | 0 | ||||||||||||||||
| Reséndiz-Colorado et al (2023)128 | X | X | X | |||||||||||||||||
| Oceania | ||||||||||||||||||||
| McFarren et al (1960)109 | X | >100 | X | |||||||||||||||||
| Rhodes et al (1975)129 | X | X | X | X | 15 | 8 | ||||||||||||||
| Eason and Harding (1987)70 | X | X | X | 2 | 1 | |||||||||||||||
| MacLean (1989)102 | X | X | X | |||||||||||||||||
| Bankoff (1999)42 | X | X | X | |||||||||||||||||
| Lehane (2001)100 | X | X | X | |||||||||||||||||
| Turnbull et al (2013)163 | X | X | X | |||||||||||||||||
| Arnich and Thébault (2018)35 | X | X | X | X | X | X | X | X | 0 | 1 | ||||||||||
| Edwards et al (2018)12 | X | X | X | 1 | 3 | |||||||||||||||
| South America | ||||||||||||||||||||
| Vecchio et al (1986)167 | X | X | X | X | X | X | ||||||||||||||
| Montebruno (1993)116 | X | X | 6 | 144 | ||||||||||||||||
| Montebruno (1993)117 | X | X | X | X | X | 1 | 9 | |||||||||||||
| García et al (2004)74 | X | X | 0 | 2 | ||||||||||||||||
| La Barbera-Sánchez et al (2004)13 | X | X | X | |||||||||||||||||
| García et al (2005)75 | X | X | X | |||||||||||||||||
| Hernández et al (2005)85 | X | X | X | |||||||||||||||||
| James et al (2010)92 | X | X | X | |||||||||||||||||
| Arnich and Thébault (2018)35 | X X | X | X | X | X | X | X | 0 | 6 | |||||||||||
| Barría et al (2022)45 | X | X | X | |||||||||||||||||
| Mafra et al (2023)103 | X | X | X | |||||||||||||||||
| Global | ||||||||||||||||||||
| Lehane (2001)100 | X | X | X | |||||||||||||||||
| Sinno-Tellier et al (2023)141 | X | X | X | |||||||||||||||||
Other represents the studies in which only one race or ethnicity was reported while that of several participants was not defined (eg, Gessner and Schloss (1996)78). Ages and races or ethnicities were not stratified by continent; therefore, if they were described in case descriptions, we indicated them with an “X” in the table. However, as sex was stratified, we listed the count for each sex when identified. We report our results with fidelity to our data extraction form (appendix pp 39–44).
Table 3:
Outbreak severity
| Number of cases | % hospitalised (n) | % required intensive care (n) | % died (n) | Earliest onset time (%) |
Minimum and maximum reported duration of symptoms | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| <30 min | 1–4 h | >4–12 h | >12 h | Not reported | ||||||
| Africa before 2000 | ≥207 | 6⋅8% (14) | 0 | 5⋅8% (12) | 100% | 0 | 0 | 0 | 0 | 36–48 h |
| Africa during or after 2000 | 23 | 0 | 0 | 0 | 36–48 h | |||||
| Asia before 2000 | ≥7854 | 5⋅6% (443) | 1 | 5⋅0% (396) | 31% | 19% | 0 | 0 | 50% | 2 h to 9 days |
| Asia during or after 2000 | ≥574 | 16⋅0% (92) | 0 | 5⋅7% (33) | 1 h to 9⋅5 days | |||||
| Europe before 2000 | ≥4447 | 2⋅3% (101) | 0 | 3⋅1% (140) | 17% | 30% | 0 | 4% | 48% | 9 h to 3 months |
| Europe during or after 2000 | ≥19 | 57⋅9% (11) | 15⋅8% (3) | 0 | Not reported | |||||
| North America before 2000 | ≥10 187 | 2⋅7% (279) | 0⋅2% (16) | 12⋅3% (1258) | 32% | 15% | 0 | 0 | 50% | 30 min to 18 days |
| North America during or after 2000 | ≥438 | 4⋅6% (20) | 1⋅6% (7) | 9⋅1% (40) | 2 h to 45 days | |||||
| Oceania before 2000 | ≥81 | 23⋅5% (19) | 1⋅2% (1) | 11⋅1% (9) | 75% | 25% | 0 | 0 | 0 | 1 week |
| Oceania during or after 2000 | ≥5 | 60⋅0% (3) | 0 | 0 | 31 h | |||||
| South America before 2000 | ≥1375 | 27⋅4% (377) | 0⋅4% (5) | 7⋅4% (102) | 50% | 0 | 0 | 0 | 50% | Not reported |
| South America during or after 2000 | ≥204 | 0 | 2⋅0% (4) | 7⋅8% (16) | 3–18 h | |||||
Percentages are based on the continent-specific and time-specific case totals. When cases were reported as ≥X, X was used to produce conservative percentages. The percentage of earliest onset time was calculated using total outbreaks rather than total cases. One study was excluded due to indiscriminate geography,141 nine studies were entirely excluded due to indiscriminate temporality,35,38,69,89,100,101,127,144,147 six studies were excluded for having outbreak periods that spanned our time stratification (eg, the outbreak started in 1999 and ended in 2008),25,37,40,79,85,128 and one study had instances of both.142
Article characteristics
The characteristics of the 152 included articles are summarised in table 1, with additional details in the appendix (pp 1–6, 15–24). Most articles (127 [83⋅6%]) were written in English, and 91 (59⋅9%) articles were published before 2000. The median (25th–75th percentile) number of PSP outbreaks reported per article was one.1–5 PSP outbreaks were documented across all continents—Africa, the Americas, Asia, Europe, and Oceania. However, among the 135 articles that reported outbreaks confined to a single continent, 120 (88⋅9%) described outbreaks occurring in North America, Asia, or Europe. Demographic data (age, race or ethnicity, and sex) of PSP cases were infrequently reported: age was reported in 51 (37⋅8%) articles, race or ethnicity in 12 (8⋅9%), and sex in 52 (38⋅5%). Furthermore, PSP was reported to affect individuals across the lifespan—from infancy to more than 80 years of age—and occurred in both sexes.
Details of seafood exposure are presented by continent in table 2. Across all regions except Africa, the most common route of exposure was via the consumption of molluscs or other shellfish. In Africa, the specific type of seafood exposure was typically unspecified. The outbreak characteristics by continent and year (<2000 vs 32000) are presented in table 3. Across all continents, 409 (77⋅0%) of 531 outbreaks were reported before 2000, during which the hospitalisation rates ranged from 2⋅3% (Europe) to 27⋅4% (South America). The percentage of cases requiring intensive care ranged from 0% (Africa and Europe) to 1⋅2% (Oceania). Case fatality rates ranged from 3⋅1% (Europe) to 12⋅3% (North America). Since 2000, hospitalisation rates have ranged from 0% (Africa and South America) to 60⋅0% (Oceania), whereas the proportion of cases requiring intensive care ranged from 0% (Africa, Asia, and Oceania) to 15⋅8% (Europe). The fatality percentage ranged from 0% (Africa, Europe, and Oceania) to 9⋅1% (North America). When symptom onset time was reported, most cases reported symptom onset time of less than 30 min in Africa (two [100%] of two), Asia (eight [57⋅1%] of 14), North America (20 [64⋅5] of 31), Oceania (two [50%] of four), and South America (four [100%] of four). In contrast, most cases (seven [63⋅6%] of 11) in Europe reported a symptom onset time of 1–4 h. The duration of reported symptoms ranged from 30 min to 45 days. The appendix (p 45) shows the percentage of clinical characteristics and symptoms reported by continent. Among articles that reported symptoms, perioral paraesthesia was the most common (ranging from ten [41⋅7%] of 24 in Europe to two [100%] of two in Africa and four [100%] of four in Oceania). Paralysis was the least reported symptom, ranging from two (8⋅3%) of 24 cases in Europe to one (50⋅0%) of two cases in Africa. Other reported symptoms across continents included paraesthesia in the arms and legs, ataxia or weakness, headache, dysarthria, respiratory distress, nausea or vomiting, dizziness, and dysphagia. No symptoms were reported in 61 (45⋅2%) of 135 articles (ranging from 0% in Africa and Oceania to 55⋅6% in South America).
Table 2:
Seafood exposure details
| Outbreaks (n) | Risk factors or exposures (%) |
Specific food or specific exposure | Toxigenic algae responsible | Shellfish origin (%) |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molluscs or shellfish | Fish | Algae or water | Multiple exposures | Unspecified | Personal | Bought at market or store | Consumed in restaurant or catered party | Multiple exposures | Not reported | ||||
| Africa | 3 | 100% | 0 | 0 | 0 | 0 | Blue mussels (Mytilus edulis L), Donax clams (Unspecified species) |
Gymnodinium catenatum | 0 | 0 | 33% | 0 | 67% |
| Asia | 76 | 66% | 0 | 0 | 11% | 24% | Asian moon scallops (Amusium pleuronectes), Asiatic hard clam (Meretrix meretrix), Black olive (Oliva vidua fulminans), Blue mussels (Mytilus edulis L), Comb pen shell (Atrina pectinata), Flag pen shell (Atrina vexillum), Fanshell clam (Pinna muricata), Flat oyster (Ostrea edulis), Giant ezo (Mizuhopecten yessoensis), Green mussels (Mytilus smaragdinus and Perna viridis), Korean mud snail (Bullacta exarata), Purple clams (Nuttallia obscurata), Queen scallop (Aequipecten opercularis), Sea pineapple (Halocynthia roretzi), Short-necked clams (Paratapes undulatus) |
Alexandrium tamarense (A tamarensis), Gymnodinium catenatum, Pyrodinium bahamense var compressum |
13% | 12% | 0 | 9% | 66% |
| Europe | 76 | 54% | 0 | 0 | 30% | 16% | Blue mussels (Mytilus edulis L), Butter clams (Saxidomus giganteus*), Dog cockles (Glycymeris glycymeris), Donax clams (Unspecified species), Pacific littleneck clams (Protothaca staminea*), Northumbrian mussel (Unspecified species), Whelks (Unspecified species) |
Alexandrium catenella (Gonyaulax excavata), Alexandrium tamarense (A tamarensis), Gymnodinium catenatum, Prorocentrum cordatum (P minimum) |
5% | 4% | 1% | 1% | 88% |
| North America | 337 | 53% | 1% | 0 | 25% | 21% | Black clams (Villorita cyprinoides), Blue mussels (Mytilus edulis), Butter clams (Saxidomus giganteus*), California mussels (Mytilus californianus), Crab (Unspecified species), Concha negra clams (Anadara tuberculosa), Cow oyster (Spondylus calcifer*), Dog winkle (Nucella lapillus), Heart cockles (Clinocardium nuttalli), Mackerel (Unspecified species), Pacific littleneck clam (Protothaca staminea*), Pufferfish (Unspecified species), Razor clams (Siliqua patula and Tagelus sp), Rock oysters (Crassostrea iridescens and Striostrea prismatica), Scad (Unspecified species), Soft shell clams (Mya arenaria), Sea snail (Unspecified species) |
Alexandrium catenella, Alexandrium monilatum, Lingulodinium poleydra (Gonyaulax poliedrum†), Alexandrium tamarense (A tamarensis), Donax kindermanni (Amphichaena kindermani), Ceratium virgatum (C rubrum), Dinophysis acuta, Gymnodinium catenatum, Mesodinium rubrum, Plicopurpura columellaris, Prorocentrum cordatum (P minimum), Pyrodinium bahamense (including compressum variant) |
11% | 0 | 0 | 29% | 59% |
| Oceania | 5 | 100% | 0 | 0 | 0 | 0 | Mediterranean mussel (Mytilus galloprovincialis), Rock oysters (Crassostrea gigas) |
Alexandrium tamarense (A tamarensis) | 100% | 0 | 0 | 0 | 0 |
|
South
America |
35 | 17% | 0 | 0 | 0 | 83% | Chilean mussels (Mytilus platensis), Ribbed mussels (Aulacomya ater) |
Alexandrium catenella,
Gonyaulax polygramma, Alexandrium tamarense (A tamarensis), Tripos furca (Ceratium furca), Chaetoceros neogracile (C gracilis)174 Margalefidinium polykrikoides (Cochlodinium polikrikoides), Cyclotella sp, Dinophysis cf acuminata, Dinophysis acuta, Mesodinium rubrum, Navicula sp, Neoporphyra seriata, Nuclearia delicatula, Pyrodinium bahamense |
6% | 0 | 0 | 0 | 94% |
| Global | ≥200 | 0 | 0 | 0 | 100% | Unspecified species | Unspecified species | 0 | 0 | 0 | 100% | ||
Percentages are based on continent-specific outbreak totals. The Personal category in Shellfish origin column included personal fishing, clamming, and subsistence harvesting. Articles reporting outbreaks from multiple continents (n=16) were excluded from this table because these categories were not stratified by continent, but articles reporting multiple outbreaks from a single continent were included. Sinno-Tellier and colleagues141 were excluded due to indiscriminate geography, and literature reviews were excluded due to no continent stratification for these data. Some algal species mentioned in articles are synonyms or no longer accepted species names; in these cases, we use the currently accepted species name followed by the name mentioned in the article in parentheses. Unless otherwise noted, taxonomic identifications were from a study by Guiry and Guiry.175
The species names reported in the original sources are no longer valid but are reported here for fidelity.
Authors listed Gonyaulax poliedrum; they were probably referring to Gonyaulax polyedra, which is now known as Lingulodinium polyedra.
Findings of risk of bias and quality of evidence assessments
The appendix (pp 25–38) summarises the findings of risk of bias and quality of evidence assessments. Most articles (102 [67⋅1%] of 152) were authored by groups with at least one government affiliation, and 71 (46⋅7%) articles were authored by groups affiliated with one or more universities or academic institutions. Furthermore, 123 (80⋅9%) articles were published by author groups affiliated with the departments of medicine or public health. In contrast, only a few articles (51 [33⋅6%]) included author groups having at least one author affiliated with ecology or environmental science departments. Regarding funding, 40 (26⋅3%) articles were sponsored by government sources, six (4⋅0%) by non-government sources, three (2⋅0%) were unsponsored, and 110 (72⋅4%) did not report funding sources.
In terms of study design, the majority of articles (67 [44⋅1%] of 152) were either case series or case reports; 45 (29⋅6%) articles were ecological or time-series or surveillance articles; 38 (25⋅0%) were literature reviews that reported individual outbreak data; and two (1⋅3%) were classified as other (including case–control studies and chemical analyses linked to outbreak data). The studies evaluated in this Review included only one PSP community surveillance survey conducted on Kodiak Island in Alaska in 1994.78 The case definition used for PSP was categorised as definite in 51 (33⋅6%) articles, probable in 32 (21⋅1%), possible in five (3⋅3%), and not specified in 64 (42⋅1%). Only 19 (12⋅5%) articles identified a target population to which findings could be generalised.
Based on the available data and risk of bias assessment findings from the articles identified, which were largely case reports and outbreak summaries with only one population-based epidemiological article, the quality of evidence was poor.
Discussion
The principal finding of this epidemiological review is that PSP represents a genuine global public health concern. PSP cases were reported across Africa, Asia, the Americas, Oceania, and Europe, with substantial consistencies in symptom profiles across these regions. Commonly reported symptoms included ataxia or weakness, nausea or vomiting, paraesthesia of the arms and legs, and perioral paraesthesia. Furthermore, dizziness or vertigo, dysarthria, paralysis, and respiratory distress have been reported across geographical regions. Although dysphagia was reported in more than three cases in North America (n=9), under-reporting of dysphagia is common.176 The presence of some symptoms in only one geographical area could reflect underlying case heterogeneity that is difficult to evaluate from the scarce epidemiological literature. Case subtype variation is a plausible basis for expecting PSP case subtype heterogeneity owing to the regional differences in the occurrence of PSP toxin-producing algae. For instance, although Alexandrium spp is the most well-known toxigenic algae,177 other genera such as Gymnodinium catenatum and Pyrodinium bahamense also produce PSP toxins.177–179
Therefore, the specific congener composition of toxins varies by algal taxa; however, transformations of toxins within marine organisms such as clams180 might expose consumers of different seafood organisms in the same contaminated ecosystem to different toxin mixtures. Therefore, comparative epidemiological surveys using standardised protocols in different geographical settings would be valuable to understand the possibility of case presentation differences and whether these differences vary according to environmental conditions and algal community composition.
A wide range of seafood species could be contaminated with PSP toxins. Although most cases are linked to the consumption of bivalve shellfish (eg, clams, mussels, cockles, and oysters), other vectors include sea snails, crabs, and, less commonly, finfish such as pufferfish and mackerel.6,25,49,62,83,102,104,165,172 Although PSP toxin exposure through marine biota other than shellfish has been described,181–183 alternative routes of exposure are more often characterised for marine wildlife such as whales and seabirds.184 Even though exposure to PSP toxins through sources other than bivalves is rare, monitoring programmes often focus only on bivalves.185 These findings suggest that greater attention should be paid to alternative vectors not yet completely incorporated into public health surveillance frameworks.
Several key limitations affected both the evidence base and our review process. First, the literature is dominated by case reports, case series, and outbreak summaries, which are insufficient for estimating the incidence of mild or moderate disease. Furthermore, case reports often highlight unusual or severe presentations, and typical cases can go undocumented in the peer-reviewed literature. Despite the availability of some quantitative data for broad comparisons (eg, historical numbers of cases in a region over a given period or the relative occurrence of outbreaks before vs after 2000), the data are not robust enough for estimating population-level incidence. The articles included in the analysis in this Review comprised case reports, case series, and outbreak investigations, with only one single population-based surveillance study from Kodiak Island, Alaska, conducted in 1994.78 This scarcity of systematic data makes drawing inferences about time trends in true population poisoning rates difficult rather than events sporadically published in peer-reviewed literature. Furthermore, several of the reports that we identified were redundant in describing the same outbreaks. For example, a collection of mussels from Spain was shipped to Switzerland, where they caused a mass outbreak of PSP among more than 200 people.51,173 This single outbreak event was described in contemporary articles published in multiple languages. The level of detail surrounding individual outbreaks was scarce in many reports, and many articles summarised historical outbreaks. Consequently, distinguishing between unique outbreaks across the epidemiological literature was deemed infeasible, representing an important limitation for burden estimation—particularly in the context of climate change, which is expected to influence the future risk of PSP.14–18 In addition to the published epidemiological literature being somewhat challenging to interpret, our review process itself had several limitations. Although we included results from relevant articles published in any language, budgetary barriers precluded paying for language translation services for every article. Therefore, we relied on colleagues for some of the decision making and data extraction for articles written in languages not spoken by our primary research team but for which we had at least two proficient-in-the-language contacts. These contributors are noted in the Acknowledgments. Finally, it is important to note that this Review focused solely on human cases. Toxins occurring in marine food webs are naturally a One Health topic, and there is also an important and growing literature on the veterinary and ecological implications of PSP-causing toxin exposures for marine wildlife that was beyond the scope of our review.186,187
This Review has implications for PSP disease prevention, public health tracking, and scientific opportunities in planetary health science. Clinicians and consumers should be aware that PSP can result from the consumption of a broader range of marine species beyond bivalves. Furthermore, this Review informs that public health practitioners could strengthen epidemiologic surveillance efforts by not limiting case definitions to require that people have consumed shellfish. Finally, in light of the need for a more systematic approach to epidemiological tracking of PSP and major ongoing efforts of the global ocean science community to protect the public from marine toxin hazards,188 including advancements in PSP monitoring189 and toxicology relevant to PSP,190,191 we want to echo other recent calls for public health scientists to engage in interdisciplinary collaborations around oceans and human health.2 Generating quantitative insights into the relative risks of PSP for consumers of various seafood types and evaluating the extent to which PSP case heterogeneity exists and has marine ecological determinants would require new interdisciplinary studies with epidemiologists working with marine biology input throughout the research process.
Conclusions
The science of PSP epidemiology remains constrained by peer-reviewed literature that predominantly comprises outbreak reports rather than systematically collected data from larger populations at risk. Nevertheless, PSP cases have been documented on all continents, and some PSP cases occurred by exposure to toxins through seafood other than the eponymous shellfish, including crab, fish, sea snails, and tunicates. We recommend more interdisciplinary collaborations between public health practitioners and ocean scientists to better characterise the population burden, environmental risk factors, and phenotypic presentations of PSP.
Supplementary Material
Panel: Search queries used in each database on Aug 8, 2022, with updated searches on Feb 20, 2023, and March 26, 2024 (restricted to document-type article, early access).
PubMed
((((“paralytic shell fish” OR “paralytic shellfish” OR “PSP” OR saxitoxin* OR “Shellfish Poisoning”[MeSH] OR (Neurotoxicity Syndromes[MeSH] OR “Neurotoxins”[MeSH] OR “Poisons”[MeSH] OR “toxin” OR “dinoflagellate*” OR “phytoplankton” OR “harmful algal bloom*” OR “Harmful Algal Bloom”[MeSH] OR “paresthesia” OR “dysesthesia” OR “Paresthesia”[MeSH] OR ((“paralysis” OR “Paralysis”[MesH] OR “respiratory failure” OR “Respiratory Insufficiency”[MeSH] OR “mechanical ventilation” OR “Respiration, Artificial”[MeSH] OR “orotracheal intubation” OR “Intubation, Intratracheal”[MeSH]) NOT (“Vocal Cord Paralysis”[MeSH] OR “vocal fold*” OR “airway stenosis” OR sleep-related))) AND ((“shellfish” OR “seafood*” OR “sea food*” OR ((“marine” OR “coastal” OR “traditional” OR “subsistence”) AND (“nutrition” OR “diet” OR food* OR “harvest”)) OR “eating” OR “ate the” OR “mollusc” OR “Mollusca”[MeSH] OR “Saxidomus” OR “clam” OR “mussel” OR “oyster” OR “geoduck” OR “lifeway*”) NOT (“arsenic” OR “mercury” OR “Hg” OR “methylmercury” OR “MeHg” OR “methyl mercury” OR “hydrargyrum” OR “pesticide”))))
AND
(epidem* OR “pandemic” OR “Case Series” OR “public health” OR “Public Health”[MeSH] OR “Environment and Public Health”[MeSH] OR “clinical toxicology” OR “toxinology” OR “prevalence” OR “Prevalence”[MeSH] OR “morbidity” OR “Morbidity”[MeSH] OR “incidence” OR “Incidence”[MeSH] OR “mortality” OR “Mortality”[MeSH] OR “population” OR “surveillance” OR “Population Surveillance”[MeSH] OR “Population Health”[MeSH] OR “Poison Control Centers”[MeSH] OR “Poison Information*” OR “Poison Center*” OR “Emergency Room*” OR “Emergency Service, Hospital” [mesh] OR “travel medicine” OR “Travel Medicine”[MeSH] OR “Population Health Management”[MeSH] OR “Vulnerable Populations”[MeSH] OR “death” OR “died” OR “diagnosis” OR “diagnosed” OR “reported” OR “vital statistics” OR “Vital Statistics”[MeSH])) NOT (“animals”[MeSH Terms] NOT “humans”[MeSH Terms])) NOT (“exposure assessment” OR “risk assessment” OR “Risk Assessment”[MeSH])
Embase
((‘paralytic shellfish poisoning’/exp OR ‘paralytic shellfish’ OR “paralytic shell fish”) AND ‘article’/it) NOT (‘animals’/exp NOT ‘humans’/exp)
Scopus
((TITLE-ABS-KEY (“paralytic shell fish” OR “paralytic shellfish” OR psp OR saxitoxin* OR toxin OR dinoflagellate* OR phytoplankton OR “harmful algal bloom” OR paresthesia OR dysesthesia OR “paralysis” OR “respiratory failure” OR “mechanical ventilation” OR “orotracheal intubation”)) AND (TITLE-ABS-KEY (shellfish OR “seafood” OR “sea food” OR “eating” OR “ate the” OR “mollusc” OR “Saxidomus” OR “clam” OR “mussel” OR “oyster” OR “geoduck” OR “lifeway”) AND (TITLE-ABS-KEY (epidem* OR “pandemic” OR “Case Series” OR “public health” OR “clinical toxicology” OR toxinology OR preva-lence OR morbidity OR incidence OR mortality OR population OR surveillance OR “Poi-son Information” OR “Poison Center” OR “Emergency Room” OR “travel medicine” OR “death” OR “died” OR diagnosis OR diagnosed OR reported OR “vital statistics”))) AND NOT (ALL (“exposure assessment” OR “risk assessment” OR “vocal fold” OR “airway ste-nosis” OR “sleep related” OR arsenic OR mercury OR hg OR methylmercury OR mehg OR “methyl mercury” OR hydrargyrum OR pesticide)) AND (LIMIT-TO (DOCTYPE, “ar”))
Web of Science
ALL=(“paralytic shellfish” OR “paralytic shell fish”) NOT ALL=(“exposure assessment” OR “risk assessment” OR “vocal fold” OR “airway stenosis” OR “sleep related” OR arsenic OR mercury OR Hg OR methylmercury OR MeHg OR “methyl mercury” OR hydrargyrum OR pesticide)
Acknowledgments
The study was funded by the National Institute of Environmental Health Sciences (R01ES029165 and P01ES035551), National Science Foundation (award #2421823), and the University of Alabama at Birmingham. WB and JML were supported by NIH/NIEHS T32 ES007069 and the Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA, USA. HBR was supported by NIH T32 CA047888 at the University of Alabama at Birmingham. The sponsors had no role in the design of this review nor any role during review execution, analyses, interpretation of the data, or decision to submit results. We thank Elisa Berdalet, Kelsie Cassell, Howard Chang, Mireille Chinain, Jutta Dierkes, Miriam Friedemann, Clémence Gatti, Jim Harley, Eunha Hoh, Joseph Kuo, Markus Lipp, Eri Saikawa, Ruth Wimsatt, Petter Steen, Emma Yu, and Zhen Cong for their assistance with processing non-English manuscripts, providing harmful algal blooms-related information, or assisting with article processing and data extraction.
Footnotes
Declaration of interests
We declare no competing interests.
See Online for appendix
Contributor Information
Matthew O Gribble, Division of Occupational, Environmental, and Climate Medicine, Department of Medicine, University of California, San Francisco, CA, USA.
Baylin J Bennett, Division of Occupational, Environmental, and Climate Medicine, Department of Medicine, University of California, San Francisco, CA, USA.
Jahred M Liddie, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
William Borchert, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Brigitte A Pfluger, Nutrition and Health Sciences, Laney Graduate School, Emory University, Atlanta, GA, USA.
Jackson S Segars, Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, USA.
Jacob M Keast, University of Exeter Medical School, St. Luke’s Campus, Exeter, Devon, UK.
Avneet Hans, Heersink School of Medicine, Birmingham, AL, USA.
Nidhi S Kikkeri, Heersink School of Medicine, Birmingham, AL, USA.
Caitlin Shin, California University of Science and Medicine, Colton, CA, USA.
Hugh B Roland, Department of Health Policy and Organization, University of Alabama at Birmingham, Birmingham, AL, USA.
Sneha Hoysala, Rollins School of Public Health, Atlanta, GA, USA.
Jacob Kohlhoff, Sitka Tribe of Alaska, Sitka, AK, USA.
Barrak Alahmad, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Shivaraj Nagalli, Shelby Baptist Medical Center, Alabaster, AL, USA.
William Rushton, Heersink School of Medicine, Birmingham, AL, USA.
Henrik Enevoldsen, Intergovernmental Oceanographic Commission Science and Communication Centre on Harmful Algae, IOC UNESCO, Copenhagen, Denmark.
Megan Bell, University of Alabama at Birmingham Libraries, Birmingham, AL, USA.
Damiana Fortenberry, University of Alabama at Birmingham Libraries, Birmingham, AL, USA.
John R Harley, Alaska Coastal Rainforest Center, University of Alaska Southeast, Juneau, AK, USA.
Andrea L C Schneider, Department of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
Data sharing
The dataset generated in this review has been registered with Harvard Dataverse, a public data repository, at https://doi.org/10.7910/DVN/ARDWAU.
References
- 1.Intergovernmental Oceanographic Commission. Implementation plan: The United Nations decade of ocean science for sustainable development 2021–2030. 2021. https://unesdoc.unesco.org/ark:/48223/pf0000377082 (accessed April 8, 2025).
- 2.Fleming LE, Depledge M, Bouley T, et al. The ocean decade-opportunities for oceans and human health programs to contribute to public health. Am J Public Health 2021; 111: 808–11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Crona BI, Wassénius E, Jonell M, et al. Four ways blue foods can help achieve food system ambitions across nations. Nature 2023; 616: 104–12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Sirot V, Leblanc JC, Margaritis I. A risk-benefit analysis approach to seafood intake to determine optimal consumption. Br J Nutr 2012; 107: 1812–22. [DOI] [PubMed] [Google Scholar]
- 5.Moore SK, Cline MR, Blair K, Klinger T, Varney A, Norman K. An index of fisheries closures due to harmful algal blooms and a framework for identifying vulnerable fishing communities on the U.S. West Coast. Mar Policy 2019; 110: 103543. [Google Scholar]
- 6.Knaack JS, Porter KA, Jacob JT, et al. Case diagnosis and characterization of suspected paralytic shellfish poisoning in Alaska. Harmful Algae 2016; 57: 45–50. [DOI] [PubMed] [Google Scholar]
- 7.Scovronick N, Vasquez VN, Errickson F, et al. Human health and the social cost of carbon: a primer and call to action. Epidemiology 2019; 30: 642–47. [DOI] [PubMed] [Google Scholar]
- 8.Gessner BD, Middaugh JP, Doucette GJ. Paralytic shellfish poisoning in Kodiak, Alaska. West J Med 1997; 167: 351–53. [PMC free article] [PubMed] [Google Scholar]
- 9.Akaeda H, Takatani T, Anami A, Noguchi T. Mass outbreak of paralytic shellfish poisoning due to ingestion of oysters at Tamano-ura, Goto Islands, Nagasaki, Japan. J Food Hyg Soc Jpn 1998; 39: 272–74. [Google Scholar]
- 10.de Carvalho M, Jacinto J, Ramos N, de Oliveira V, Pinho e Melo T, de Sá J. Paralytic shellfish poisoning: clinical and electrophysiological observations. J Neurol 1998; 245: 551–54. [DOI] [PubMed] [Google Scholar]
- 11.Popkiss ME, Horstman DA, Harpur D. Paralytic shellfish poisoning. A report of 17 cases in Cape Town. S Afr Med J 1979; 55: 1017–23. [PubMed] [Google Scholar]
- 12.Edwards LJ, Wilson K, Veitch MG. An outbreak of paralytic shellfish poisoning in Tasmania. Commun Dis Intell 2018; 2018: 42. [DOI] [PubMed] [Google Scholar]
- 13.La Barbera-Sánchez A, Franco Soler J, Rojas de Astudillo L, Chang-Yen I. Paralytic shellfish poisoning (PSP) in Margarita Island, Venezuela. Rev Biol Trop 2004; 52 (suppl 1): 89–98. [PubMed] [Google Scholar]
- 14.Wells ML, Trainer VL, Smayda TJ, et al. Harmful algal blooms and climate change: learning from the past and present to forecast the future. Harmful Algae 2015; 49: 68–93. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Anderson DM, Fensin E, Gobler CJ, et al. Marine harmful algal blooms (HABs) in the United States: history, current status and future trends. Harmful Algae 2021; 102: 101975. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Etheridge SM. Paralytic shellfish poisoning: seafood safety and human health perspectives. Toxicon 2010; 56: 108–22. [DOI] [PubMed] [Google Scholar]
- 17.GlobalHAB. Guidelines for the study of climate change effects on HABs. 2021. https://unesdoc.unesco.org/ark:/48223/pf0000380344 (accessed July 24, 2024).
- 18.Brandenburg KM, Velthuis M, Van de Waal DB. Meta-analysis reveals enhanced growth of marine harmful algae from temperate regions with warming and elevated CO2 levels. Glob Chang Biol 2019; 25: 2607–18. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Bill BD, Moore SK, Hay LR, Anderson DM, Trainer VL. Effects of temperature and salinity on the growth of Alexandrium (Dinophyceae) isolates from the Salish Sea. J Phycol 2016; 52: 230–38. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Braga AC, Camacho C, Marques A, Gago-Martínez A, Pacheco M, Costa PR. Combined effects of warming and acidification on accumulation and elimination dynamics of paralytic shellfish toxins in mussels Mytilus galloprovincialis. Environ Res 2018; 164: 647–54. [DOI] [PubMed] [Google Scholar]
- 21.Roggatz CC, Fletcher N, Benoit DM, et al. Saxitoxin and tetrodotoxin bioavailability increases in future oceans. Nat Clim Change 2019; 9: 840–44. [Google Scholar]
- 22.Tshala-Katumbay D, Mwanza JC, Rohlman DS, Maestre G, Oriá RB. A global perspective on the influence of environmental exposures on the nervous system. Nature 2015; 527: S187–92. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.GBD 2016 Neurology Collaborators. Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the global burden of disease study 2016. Lancet Neurol 2019; 18: 459–80. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.GBD 2021 Nervous System Disorders Collaborators. Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the global burden of disease study 2021. Lancet Neurol 2024; 23: 344–81. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.McIntyre L, Miller A, Kosatsky T. Changing trends in paralytic shellfish poisonings reflect increasing sea surface temperatures and practices of indigenous and recreational harvesters in British Columbia, Canada. Mar Drugs 2021; 19: 568. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Kim JY, Lee CU, Jun JH, et al. An epidemiologic study of paralytic shellfish poisoning. J Korean Med Assoc 1986; 29: 896–905 [in Korean]. [Google Scholar]
- 27.Mohammad Hassan M, Shahnaz S, Samir H, Fateh B. Methodological quality and synthesis of case series and case reports. BMJ Evid Based Med 2018; 23: 60. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Sterne JA, Hernán MA, Reeves BC, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ 2016; 355: i4919. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Wells GA, Shea B, O’Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses, 2000. https://www.ohri.ca/programs/clinical_epidemiology/oxford.asp (accessed July 24, 2024).
- 30.Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008; 336: 924–26. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Robinson R, Champetier de Ribes G, Ranaivoson G, Rejely M, Rabeson D. KAP study (knowledge-attitude-practice) on seafood poisoning on the southwest coast of Madagascar. Bull Soc Pathol Exot 1999; 92: 46–50 [in French]. [PubMed] [Google Scholar]
- 32.Acres J, Gray J. Paralytic shellfish poisoning. Can Med Assoc J 1978; 119: 1195–97. [PMC free article] [PubMed] [Google Scholar]
- 33.Ahmed FE. Naturally occurring seafood toxins. J Toxicol Toxin Rev 1991; 10: 263–87. [Google Scholar]
- 34.Ahmed FE. Review: assessing and managing risk due to consumption of seafood contaminated with micro-organisms, parasites, and natural toxins in the US. Int J Food Sci Technol 1992; 27: 243–60. [Google Scholar]
- 35.Arnich N, Thébault A. Dose-response modelling of paralytic shellfish poisoning (PSP) in humans. Toxins (Basel) 2018; 10: 141. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Ayres PA. Mussel poisoning in Britain with special reference to paralytic shellfish poisoning. A review of cases reported 1814–1968. Envir Hlth 1975; 83: 261–65. [Google Scholar]
- 37.Azanza MPV. Philippine foodborne-disease outbreaks (1995–2004). J Food Saf 2006; 26: 92–102. [Google Scholar]
- 38.Azanza RV, Taylor FJ. Are Pyrodinium blooms in the Southeast Asian region recurring and spreading? A view at the end of the millennium. Ambio 2001; 30: 356–64. [PubMed] [Google Scholar]
- 39.Azzeri A, Ching GH, Jaafar H, et al. A review of published literature regarding health issues of coastal communities in Sabah, Malaysia. Int J Environ Res Public Health 2020; 17: 1533. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Bajarias FFA, Furio EF, Gonzales CL, Sakamoto S, Fukuyo Y, Kodama M. Localizing PSP monitoring in the Philippines: a management option. Fish Sci 2002; 68 (sup1): 519–22. [Google Scholar]
- 41.Balmer-Hanchey EL, Jaykus L-A, McClellan-Green P. Marine biotoxins of algal origin and seafood safety. J Aquat Food Prod 2003; 12: 29–53. [Google Scholar]
- 42.Bankoff G Societies in conflict: algae and humanity in the Philippines. Env Hist Camb 1999; 5: 97–123. [DOI] [PubMed] [Google Scholar]
- 43.Barbier HM, Diaz JH. Prevention and treatment of toxic seafoodborne diseases in travelers. J Travel Med 2006; 10: 29–37. [DOI] [PubMed] [Google Scholar]
- 44.Barraza JE. Food poisoning due to consumption of the marine gastropod Plicopurpura columellaris in El Salvador. Toxicon 2009; 54: 895–96. [DOI] [PubMed] [Google Scholar]
- 45.Barría C, Vásquez-Calderón P, Lizama C, et al. Spatial temporal expansion of harmful algal blooms in Chile: a review of 65 years records. J Mar Sci Eng 2022; 10: 1868. [Google Scholar]
- 46.Batoréu MC, Dias E, Pereira P, Franca S. Risk of human exposure to paralytic toxins of algal origin. Environ Toxicol Pharmacol 2005; 19: 401–06. [DOI] [PubMed] [Google Scholar]
- 47.Bean NH, Goulding JS, Daniels MT, Angulo FJ. Surveillance for foodborne disease outbreaks-United States, 1988–1992. J Food Prot 1997; 60: 1265–86. [DOI] [PubMed] [Google Scholar]
- 48.Bean NH, Goulding JS, Lao C, Angulo FJ. Surveillance for foodborne-disease outbreaks–United States, 1988–1992. MMWR CDC Surveill Summ 1996; 45: 1–66. [PubMed] [Google Scholar]
- 49.Bienfang PK, Defelice SV, Laws EA, et al. Prominent human health impacts from several marine microbes: history, ecology, and public health implications. Int J Microbiol 2011; 2011: 152815. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Blanc MH, Zwahlen A, Robert M. Symptoms of shellfish poisoning. N Engl J Med 1977; 296: 287–88. [DOI] [PubMed] [Google Scholar]
- 51.Blanc MH, Zwahlen A, Robert M. Epidemic of mussel poisoning. Rev Clin Esp 1978; 150: 259–63. [PubMed] [Google Scholar]
- 52.Bond RM, Medcof JC. Epidemic shellfish poisoning in New Brunswick, 1957. Can Med Assoc J 1958; 79: 19–24. [PMC free article] [PubMed] [Google Scholar]
- 53.Bryan FL. Epidemiology of foodborne diseases transmitted by fish, shellfish and marine crustaceans in the United States, 1970–1978. J Food Prot 1980; 43: 859–72. [DOI] [PubMed] [Google Scholar]
- 54.Callejas L, Darce ACM, Amador JJ, et al. Paralytic shellfish poisonings resulting from an algal bloom in Nicaragua. BMC Res Notes 2015; 8: 74. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Caroli G, Malfatti S, Armani G. An epidemic of neurotoxic shellfish poisoning due to imported mussels. Riv Ital Ig 1978; 38: 3–11 [in Italian]. [Google Scholar]
- 56.Carvalho ILD, Pelerito A, Ribeiro I, Cordeiro R, Núncio MS, Vale P. Paralytic shellfish poisoning due to ingestion of contaminated mussels: a 2018 case report in Caparica (Portugal). Toxicon X 2019; 4: 100017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Chen J, Hong S, Zhang J, Cai M, Lin Y. Investigation into an outbreak of suspected shellfish poisoning caused by consuming Bullacta exarata. Chin J Food Hyg 2023; 35: 1231–34. [Google Scholar]
- 58.Cheng HS, Chua SO, Hung JS, Yip KK. Creatine kinase MB elevation in paralytic shellfish poisoning. Chest 1991; 99: 1032–33. [DOI] [PubMed] [Google Scholar]
- 59.Ching PK, Ramos RA, de los Reyes VC, Sucaldito MN, Tayag E. Lethal paralytic shellfish poisoning from consumption of green mussel broth, Western Samar, Philippines, August 2013. Western Pac Surveill Response J 2015; 6: 22–26. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Chung PH, Chuang SK, Tsang T. Consumption of viscera as the most important risk factor in the largest outbreak of shellfish poisoning in Hong Kong, 2005. Southeast Asian J Trop Med Public Health 2006; 37: 120–25. [PubMed] [Google Scholar]
- 61.Cladouhos JW. Paralytic shellfish poisonings reported in Alaska. Environ Health 1977; 39: 256–57. [Google Scholar]
- 62.Clemence MA, Guerrant RL. Infections and intoxications from the ocean: risks of the shore. Microbiol Spectr 2015; 3. [DOI] [PubMed] [Google Scholar]
- 63.Coleman RM, Ojeda-Torres G, Bragg W, et al. Saxitoxin exposure confirmed by human urine and food analysis. J Anal Toxicol 2018; 42: e61–64. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Conte FS. Economic impact of paralytic shellfish poison on the oyster industry in the Pacific United States. Aquaculture 1984; 39: 331–43. [Google Scholar]
- 65.Corrales RA, Maclean JL. Impacts of harmful algae on seafarming in the Asia-Pacific areas. J Appl Phycol 1995; 7: 151–62. [Google Scholar]
- 66.Cortés-Altamirano R, Hernández-Becerril DU, Luna-Soria R. Red tides in Mexico: a review. Rev Latinoam Microbiol 1995; 37: 343–52 [in Spanish]. [PubMed] [Google Scholar]
- 67.Craun GF. Waterborne outbreaks. J Water Pollut Control Fed 1977; 49: 1268–79. [PubMed] [Google Scholar]
- 68.de la Garza Aguilar J. Food poisoning caused by ingestion of contaminated shellfish. Salud Publica Mex 1983; 25: 145–50 [in Spanish]. [PubMed] [Google Scholar]
- 69.DeGrasse S, Rivera V, Roach J, et al. Paralytic shellfish toxins in clinical matrices: extension of AOAC official method 2005.06 to human urine and serum and application to a 2007 case study in Maine. Deep Sea Res II: Top Stud Oceanogr 2014; 103: 368–75. [Google Scholar]
- 70.Eason RJ, Harding E. Neurotoxic fish poisoning in the Solomon Islands. P N G Med J 1987; 30: 49–52. [PubMed] [Google Scholar]
- 71.Fortuine R Paralytic shellfish poisoning in the North Pacific: two historical accounts and implications for today. Alaska Med 1975; 17: 71–75. [PubMed] [Google Scholar]
- 72.Fortuine R Paralytic shellfish poisoning in the North Pacific: two historical accounts and implications for today. 1975. Alaska Med 2007; 49: 65–69. [PubMed] [Google Scholar]
- 73.Gacutan RQ, Tabbu MY, Aujero EJ, Icatlo F Jr. Paralytic shellfish poisoning due to Pyrodinium bahamense var. compressa in Mati, Davao Oriental, Philippines. Mar Biol 1985; 87: 223–27. [Google Scholar]
- 74.García C, del Carmen Bravo M, Lagos M, Lagos N. Paralytic shellfish poisoning: post-mortem analysis of tissue and body fluid samples from human victims in the Patagonia fjords. Toxicon 2004; 43: 149–58. [DOI] [PubMed] [Google Scholar]
- 75.García C, Lagos M, Truan D, et al. Human intoxication with paralytic shellfish toxins: clinical parameters and toxin analysis in plasma and urine. Biol Res 2005; 38: 197–205. [DOI] [PubMed] [Google Scholar]
- 76.Gessner BD, Bell P, Doucette GJ, et al. Hypertension and identification of toxin in human urine and serum following a cluster of mussel-associated paralytic shellfish poisoning outbreaks. Toxicon 1997; 35: 711–22. [DOI] [PubMed] [Google Scholar]
- 77.Gessner BD, Middaugh JP. Paralytic shellfish poisoning in Alaska: a 20-year retrospective analysis. Am J Epidemiol 1995; 141: 766–70. [DOI] [PubMed] [Google Scholar]
- 78.Gessner BD, Schloss M. A population-based study of paralytic shell fish poisoning in Alaska. Alaska Med 1996; 38: 54–58. [PubMed] [Google Scholar]
- 79.Gould LH, Walsh KA, Vieira AR, et al. Surveillance for foodborne disease outbreaks - United States, 1998–2008. MMWR Surveill Summ 2013; 62: 1–34. [PubMed] [Google Scholar]
- 80.Grimard D, Lalonde R. Paralysing shell fish poisoning. Union Med Can 1981; 110: 144–50 [in French]. [PubMed] [Google Scholar]
- 81.Gulbrandsen RK, Aalvik B. Shellfish poisoning. A short review of shellfish poisoning and a description of an outbreak. Tidsskr Nor Laegeforen 1981; 101: 452–54 [in Norwegian]. [PubMed] [Google Scholar]
- 82.Hartigan-Go K, Bateman DN. Redtide in the Philippines. Hum Exp Toxicol 1994; 13: 824–30. [DOI] [PubMed] [Google Scholar]
- 83.Hashimoto K, Noguchi T. Recent studies on paralytic shellfish poison in Japan. Pure Appl Chem 1989; 61: 7–18. [Google Scholar]
- 84.Hasselgård T, Hjelle A. Shellfish poisoning. An epidemic in the Nesset District. Tidsskr Nor Laegeforen 1984; 104: 292–94 [in Norwegian]. [PubMed] [Google Scholar]
- 85.Hernández C, Ulloa J, Vergara JA, Espejo R, Cabello F. Vibrio parahaemolyticus infections and algal intoxications as emergent public health problems in Chile. Rev Med Chil 2005; 133: 1081–88 [in Spanish]. [DOI] [PubMed] [Google Scholar]
- 86.Hinder SL, Hays GC, Brooks CJ, et al. Toxic marine microalgae and shellfish poisoning in the British Isles: history, review of epidemiology, and future implications. Environ Health 2011; 10: 54. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 87.Holmes MJ, Teo SLM. Toxic marine dinoflagellates in Singapore waters that cause seafood poisonings. Clin Exp Pharmacol Physiol 2002; 29: 829–36. [DOI] [PubMed] [Google Scholar]
- 88.Hughes JM, Horwitz MA, Merson MH, Barker WH Jr, Gangarosa EJ. Foodborne disease outbreaks of chemical etiology in the United States, 1970–1974. Am J Epidemiol 1977; 105: 233–44. [DOI] [PubMed] [Google Scholar]
- 89.Hurley W, Wolterstorff C, MacDonald R, Schultz D. Paralytic shellfish poisoning: a case series. West J Emerg Med 2014; 15: 378–81. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 90.Hwang DF, Tsai YH, Cheng CA, et al. Two food poisoning incidents due to ingesting the purple clam occurred in Taiwan. J Nat Toxins 1995; 4: 173–79. [Google Scholar]
- 91.Imbert JC, Essaïd el Feydi A, Kadiri A. Paralytic shellfish poisoning. Sem Hop 1979; 55: 1139–42 [in French]. [PubMed] [Google Scholar]
- 92.James KJ, Carey B, O’Halloran J, van Pelt FN, Skrabáková Z. Shellfish toxicity: human health implications of marine algal toxins. Epidemiol Infect 2010; 138: 927–40. [DOI] [PubMed] [Google Scholar]
- 93.Jen HC, Yen JY, Liao IC, Hwang DF. Identification of species and paralytic shellfish poisons in an unknown scallop meat implicated in food poisoning in Taiwan. Raffles Bull Zool 2008; 19: 115–22. [Google Scholar]
- 94.Kan SK, Singh N, Chan MK. Oliva vidua fulminans, a marine mollusc, responsible for five fatal cases of neurotoxic food poisoning in Sabah, Malaysia. Trans R Soc Trop Med Hyg 1986; 80: 64–65. [DOI] [PubMed] [Google Scholar]
- 95.Karlson B, Andersen P, Arneborg L, et al. Harmful algal blooms and their effects in coastal seas of northern Europe. Harmful Algae 2021; 102: 101989. [DOI] [PubMed] [Google Scholar]
- 96.Kawabata T, Yoshida T, Kubota Y. Paralytic shellfish poison–I a note on the shellfish poisoning occurred in Ofunato city, Iwate Prefecture in May, 1961. Bull Jpn Soc Sci Fish 1962; 28: 344 [in Japanese]. [Google Scholar]
- 97.Krys S, Frémy JM. Phycotoxins and seafoods: associated medical risks and preventive measures. Revue Francaise des Laboratoires 2002; 348: 29–38 [in French]. [Google Scholar]
- 98.Langeland G, Hasselgård T, Tangen K, Skulberg OM, Hjelle A. An outbreak of paralytic shellfish poisoning in western Norway. Sarsia 1984; 69: 185–93. [Google Scholar]
- 99.Ledoux M, Frémy JM. Phytoplankton, phycotoxins and seafood poisoning. Rec Med Vet 1994; 170: 129–39 [in French]. [Google Scholar]
- 100.Lehane L Paralytic shellfish poisoning: a potential public health problem. Med J Aust 2001; 175: 29–31. [DOI] [PubMed] [Google Scholar]
- 101.Long RR, Sargent JC, Hammer K. Paralytic shellfish poisoning: A case report and serial electrophysiologic observations. Neurology 1990; 40: 1310–12. [DOI] [PubMed] [Google Scholar]
- 102.Maclean JL. Indo-Pacific red tides, 1985–1988. Mar Pollut Bull 1989; 20: 304–10. [Google Scholar]
- 103.Mafra LL Jr, Sunesen I, Pires E, et al. Benthic harmful microalgae and their impacts in South America. Harmful Algae 2023; 127: 102478. [DOI] [PubMed] [Google Scholar]
- 104.Centers for Disease Control and Prevention. Neurologic illness associated with eating Florida pufferfish, 2002. MMWR Morb Mortal Wkly Rep 2002; 51: 321–23. [PubMed] [Google Scholar]
- 105.Marks CJ, Van Hoving DJ, Wium CA, et al. South African marine envenomations and poisonings as managed telephonically by the Tygerberg poisons information centre: A 20-year retrospective review. Wilderness Environ Med 2019; 30: 134–40. [DOI] [PubMed] [Google Scholar]
- 106.Martín R, García T, Sanz B, Hernández PE. Biotoxinas marinas: intoxicaciones por el consumo de moluscos bivalvos/seafood toxins: poisoning by bivalve consumption. Food Sci Technol Int 1996; 2: 13–22. [Google Scholar]
- 107.Mata L, Abarca G, Marranghello L, Víquez R. Paralytic shellfish poisoning by Spondylus calcifer contaminated with Pyrodinium bahamense, Costa-Rica, 1989–1990. Rev Biol Trop 1990; 38: 129–36 [in Spanish]. [PubMed] [Google Scholar]
- 108.McCollum JP, Pearson RC, Ingham HR, Wood PC, Dewar HA. An epidemic of mussel poisoning in North-East England. Lancet 1968; 2: 767–70. [DOI] [PubMed] [Google Scholar]
- 109.McFarren EF, Schafer ML, Campbell JE, Lewis KH, Jensen ET, Schantz EJ. Public health significance of paralytic shellfish poison. Adv Food Res 1960; 10: 135–79. [DOI] [PubMed] [Google Scholar]
- 110.McLaughlin JB, Fearey DA, Esposito TA, Porter KA. Paralytic shellfish poisoning - Southeast Alaska, May–June 2011. MMWR Morb Mortal Wkly Rep 2011; 60: 1554–56. [PubMed] [Google Scholar]
- 111.Mee LD, Espinosa M, Diaz G. Paralytic shellfish poisoning with a Gymnodinium catenatum red tide on the Pacific Coast of Mexico. Mar Environ Res 1986; 19: 77–92. [Google Scholar]
- 112.Meinke AH III, Quinn EL. Paralytic shellfish poisoning. Mich Med 1973; 72: 37–38. [PubMed] [Google Scholar]
- 113.Meyers HF, Hilliard DK. Shellfish poisoning episode in False Pass, Alaska. Public Health Rep (18ßS) 1955; 70: 419–20. [PMC free article] [PubMed] [Google Scholar]
- 114.Mills AR, Passmore R. Pelagic paralysis. Lancet 1988; 1: 161–64. [DOI] [PubMed] [Google Scholar]
- 115.Mira Gutiérrez J The man and the sea: marine phytoplancton and public health. An R Acad Nac Med (Madr) 2005; 122: 661–79 [in Spanish]. [PubMed] [Google Scholar]
- 116.Montebruno D Poisoning by the consumption of shellfish contaminated with paralytic venom in the XII Region, Chile. Anatomopathological study. Rev Med Chil 1993; 121: 94–97 [in Spanish]. [PubMed] [Google Scholar]
- 117.Montebruno D Paralytic shellfish poisoning in Chile. Med Sci Law 1993; 33: 243–46. [DOI] [PubMed] [Google Scholar]
- 118.Morris JG Jr. Harmful algal blooms: an emerging public health problem with possible links to human stress on the environment. Annu Rev Energy Environ 1999; 24: 367–90. [Google Scholar]
- 119.Morse EV. Paralytic shellfish poisoning: a review. J Am Vet Med Assoc 1977; 171: 1178–80. [PubMed] [Google Scholar]
- 120.Moss ML. Shellfish, gender, and status on the Northwest Coast: reconciling archeological, ethnographic, and ethnohistorical records of the Tlingit. Am Anthropol 1993; 95: 631–52. [Google Scholar]
- 121.Murakami R, Noguchi T. Paralytic shellfish poison. Shokuhin Eiseigaku Zasshi 2000; 41: 1–10 [in Japanese]. [Google Scholar]
- 122.Negoro K, Morimatsu M. Clinical analysis of paralytic shellfish poisoning following ingestion of oysters. Rinsho Shinkeigaku 1993; 33: 207–09 [in Japanese]. [PubMed] [Google Scholar]
- 123.No authors listed. Leads from the MMWR. Annual mussel quarantine–California, 1983. JAMA 1983; 249: 3292. [PubMed] [Google Scholar]
- 124.No authors listed. Illness due to molluscan shellfish–England and Wales. Can Dis Wkly Rep 1988; 14: 55–56. [PubMed] [Google Scholar]
- 125.None listed. Paralytic shellfish poisoning (red tide). Epidemiol Bull 1990; 11: 9. [PubMed] [Google Scholar]
- 126.None authors listed. Food safety. Paralytic shellfish poisoning. Wkly Epidemiol Rec 1991; 66: 185–87. [PubMed] [Google Scholar]
- 127.Rapala J, Robertson A, Negri AP, et al. First report of saxitoxin in Finnish lakes and possible associated effects on human health. Environ Toxicol 2005; 20: 331–40. [DOI] [PubMed] [Google Scholar]
- 128.Reséndiz-Colorado G, García-Mendoza E, Almazán-Becerril A, Medina-Elizalde J, Cepeda-Morales JA, Rivera-Caicedo JP. Towards the early detection of Gymnodinium catenatum algal blooms in the northern Gulf of California. J Mar Sci Eng 2023; 11: 1793. [Google Scholar]
- 129.Rhodes FA, Mills CG, Popei K. Paralytic shellfish poisoning in Papua New Guinea. P N G Med J 1975; 18: 197–202. [PubMed] [Google Scholar]
- 130.Rodrigue DC, Etzel RA, Hall S, et al. Lethal paralytic shellfish poisoning in Guatemala. Am J Trop Med Hyg 1990; 42: 267–71. [DOI] [PubMed] [Google Scholar]
- 131.Rodríguez F, Escalera L, Reguera B, et al. Red tides in the Galician rías: historical overview, ecological impact, and future monitoring strategies. Environ Sci Processes Impacts 2024; 26: 16–34. [DOI] [PubMed] [Google Scholar]
- 132.Roy RN. Red tide and outbreak of paralytic shellfish poisoning in Sabah. Med J Malaysia 1977; 31: 247–51. [PubMed] [Google Scholar]
- 133.Saavedra-Delgado AM, Metcalfe DD. Seafood toxins. Clin Rev Allergy 1993; 11: 241–60. [DOI] [PubMed] [Google Scholar]
- 134.Saldate Castañeda O, Vázquez Castellanos JL, Galván J, Sánchez Anguiano A, Nazar A. Poisoning by paralytic molluscan toxins in Oaxaca. Salud Publ Mex 1991; 33: 240–47 [in Spanish]. [PubMed] [Google Scholar]
- 135.Sanders WE Jr. Intoxications from the seas: ciguatera, scombroid, and paralytic shellfish poisoning. Infect Dis Clin North Am 1987; 1: 665–76. [PubMed] [Google Scholar]
- 136.Scobey RR. Paralytic shellfish disease and poliomyelitis. Arch Pediatr (N Y) 1947; 64: 350–63. [PubMed] [Google Scholar]
- 137.Scoging AC. Illness associated with seafood. CDR (Lond Engl Rev) 1991; 1: R117–22. [PubMed] [Google Scholar]
- 138.Scoging AC. Marine biotoxins. Symp Ser Soc Appl Microbiol 1998; 27: 41S–50S. [DOI] [PubMed] [Google Scholar]
- 139.Sierra-Beltrán AP, Cruz A, Núñez E, Del Villar LM, Cerecero J, Ochoa JL. An overview of the marine food poisoning in Mexico. Toxicon 1998; 36: 1493–502. [DOI] [PubMed] [Google Scholar]
- 140.Sinno-Tellier S, Abadie E, de Haro L, et al. Human poisonings by neurotoxic phycotoxins related to the consumption of shellfish: study of cases registered by the French poison control centres from 2012 to 2019. Clin Toxicol (Phila) 2022; 60: 759–67. [DOI] [PubMed] [Google Scholar]
- 141.Sinno-Tellier S, Abadie E, Guillotin S, Bossée A, Nicolas M, Delcourt N. Human shellfish poisoning: implementation of a national surveillance program in France. Front Mar Sci 2023; 9: 1089585. [Google Scholar]
- 142.Sobel J, Painter J. Illnesses caused by marine toxins. Clin Infect Dis 2005; 41: 1290–96. [DOI] [PubMed] [Google Scholar]
- 143.Suleiman M, Jelip J, Rundi C, Chua TH. Case report: paralytic shellfish poisoning in Sabah, Malaysia. Am J Trop Med Hyg 2017; 97: 1731–36. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 144.Sunesen I, Méndez SM, Mancera-Pineda JE, Dechraoui Bottein MY, Enevoldsen H. The Latin America and Caribbean HAB status report based on OBIS and HAEDAT maps and databases. Harmful Algae 2021; 102: 101920. [DOI] [PubMed] [Google Scholar]
- 145.Swaddiwudhipong W, Kunasol P, Sangwanloy O, Srisomporn D. Foodborne disease outbreaks of chemical etiology in Thailand, 1981–1987. Southeast Asian J Trop Med Public Health 1989; 20: 125–32. [PubMed] [Google Scholar]
- 146.Tangen K Shellfish poisoning and the occurrence of potentially toxic dinoflagellates in Norwegian waters. Sarsia 1983; 68: 1–7. [Google Scholar]
- 147.Temple C, Hughes A. A case of fatal paralytic shellfish poisoning in Alaska. Clin Toxicol (Phila) 2022; 60: 414–15. [DOI] [PubMed] [Google Scholar]
- 148.Tennant AD, Naubert J, Corbeil HE. An outbreak of paralytic shellfish poisoning. Can Med Assoc J 1955; 72: 436–39. [PMC free article] [PubMed] [Google Scholar]
- 149.PHLS Communicable Disease Surveillance Centre. Communicable disease report January to June 1990. J Public Health 1990; 12: 209–12. [PubMed] [Google Scholar]
- 150.Toda M, Uneyama C, Toyofuku H, Morikawa K. Trends of food poisonings caused by natural toxins in Japan, 1989–2011. Shokuhin Eiseigaku Zasshi 2012; 53: 105–20 [in Japanese]. [DOI] [PubMed] [Google Scholar]
- 151.Todd E, Avery G, Grant GA, Fenwick JC, Chiang R, Babiuk T. An outbreak of severe paralytic shellfish poisoning in British Columbia. Can Commun Dis Rep 1993; 19: 99–102. [PubMed] [Google Scholar]
- 152.Todd EC. Emerging diseases associated with seafood toxins and other water-borne agents. Ann N Y Acad Sci 1994; 740: 77–94. [DOI] [PubMed] [Google Scholar]
- 153.Todd EC. Seafood-associated diseases and control in Canada. Rev Sci Tech 1997; 16: 661–72. [DOI] [PubMed] [Google Scholar]
- 154.Todd ECD. Foodborne disease in Canada - 1974 annual summary. J Food Prot 1977; 40: 493–98. [DOI] [PubMed] [Google Scholar]
- 155.Todd ECD. Foodborne and waterborne disease in Canada - 1977 annual summary. J Food Prot 1982; 45: 865–73. [DOI] [PubMed] [Google Scholar]
- 156.Todd ECD. Foodborne and waterborne disease in Canada - 1978 annual summary. J Food Prot 1985; 48: 990–96. [DOI] [PubMed] [Google Scholar]
- 157.Todd ECD. Foodborne and waterborne disease in Canada - 1979 annual summary. J Food Prot 1985; 48: 1071–78. [DOI] [PubMed] [Google Scholar]
- 158.Todd ECD. Foodborne and waterborne disease in Canada - 1980 annual summary. J Food Prot 1987; 50: 420–28. [DOI] [PubMed] [Google Scholar]
- 159.Todd ECD. Foodborne and waterborne disease in Canada - 1982 annual summary. J Food Prot 1988; 51: 56–65. [DOI] [PubMed] [Google Scholar]
- 160.Todd ECD. Foodborne and waterborne disease in Canada - 1983 annual summary. J Food Prot 1989; 52: 436–42. [DOI] [PubMed] [Google Scholar]
- 161.Trainer VL, Sullivan K, Eberhart B- TL, et al. Enhancing shellfish safety in Alaska through monitoring of harmful algae and their toxins. J Shellfish Res 2014; 33: 531–39. [Google Scholar]
- 162.Trevino S. Fish and shellfish poisoning. Clin Lab Sci 1998; 11: 309–14. [PubMed] [Google Scholar]
- 163.Turnbull A, Harrison R, McKeown S. Paralytic shellfish poisoning in south eastern Tasmania. Commun Dis Intell Q Rep 2013; 37: E52–54. [DOI] [PubMed] [Google Scholar]
- 164.Centers for Disease Control and Prevention. Paralytic shellfish poisoning-Massachusetts and Alaska, 1990. MMWR Morb Mortal Wkly Rep 1991; 40: 157–61. [PubMed] [Google Scholar]
- 165.Centers for Disease Control and Prevention. Update: neurologic illness associated with eating Florida pufferfish, 2002. MMWR Morb Mortal Wkly Rep 2002; 51: 414–16. [PubMed] [Google Scholar]
- 166.Vale P Shellfish contamination with marine biotoxins in Portugal and spring tides: a dangerous health coincidence. Environ Sci Pollut Res Int 2020; 27: 41143–56. [DOI] [PubMed] [Google Scholar]
- 167.Vecchio JH, Gómez O, Orosco JA, Tartaglione JC, Gricman G. Poisoning by paralysing mollusk venom (red tide). Medicina (B Aires) 1986; 46: 705–08 [in Spanish]. [PubMed] [Google Scholar]
- 168.Velayudhan A, Nayak J, Murhekar MV, Dikid T, Sodha SV. Shellfish poisoning outbreaks in Cuddalore District, Tamil Nadu, India. Indian J Public Health 2021; 65 (suppl): S29–33. [DOI] [PubMed] [Google Scholar]
- 169.Viviani R. Eutrophication, marine biotoxins, human health. Sci Total Environ. 1992;(suppl): 631–62. [DOI] [PubMed] [Google Scholar]
- 170.Wang DZ. Neurotoxins from marine dinoflagellates: a brief review. Mar Drugs 2008; 6: 349–71. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 171.Yu Z, Tang Y, Gobler CJ. Harmful algal blooms in China: history, recent expansion, current status, and future prospects. Harmful Algae 2023; 129: 102499. [DOI] [PubMed] [Google Scholar]
- 172.Zheng R, Huang L, Wu Y, Lin S, Huang L. Simultaneous analysis of paralytic shellfish toxins and tetrodotoxins in human serum by liquid chromatography coupled to Q-Exactive high-resolution mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2023; 1215: 123565. [DOI] [PubMed] [Google Scholar]
- 173.Zwahlen A, Blanc MH, Robert M. Paralytic shellfish poisoning. Schweiz Med Wochenschr 1977; 107: 226–30 [in French]. [PubMed] [Google Scholar]
- 174.Kociolek JP, Blanco S, Coste M, et al. DiatomBase. Chaetoceros gracilis Schütt, 1895. July 29, 2005. https://www.marinespecies.org/aphia.php?p=taxdetails&id=178204 (accessed July 31, 2023). [Google Scholar]
- 175.Guiry MD, Guiry GM. AlgaeBase. World-wide electronic publication, National University of Ireland, Galway (taxonomic information republished from AlgaeBase with permission of M.D. Guiry). 2023. https://www.marinespecies.org/ (accessed July 31, 2023).
- 176.Leslie PS, Smithard DG. Is dysphagia under diagnosed or is normal swallowing more variable than we think? Reported swallowing problems in people aged 18–65 years. Dysphagia 2021; 36: 910–18. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 177.Anderson DM, Alpermann TJ, Cembella AD, Collos Y, Masseret E, Montresor M. The globally distributed genus Alexandrium: multifaceted roles in marine ecosystems and impacts on human health. Harmful Algae 2012; 14: 10–35. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 178.Landsberg H, Hall S, Johannessen JN, et al. Saxitoxin puffer fish poisoning in the United States, with the first report of Pyrodinium bahamense as the putative toxin source. Environ Health Perspect 2006; 114: 1502–07. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 179.Llewellyn L, Andrew N, Robertson A. Paralytic shellfish toxins in tropical oceans. Toxin Rev 2006; 25: 159–96. [Google Scholar]
- 180.Raposo MIC, Gomes MTSR, Botelho MJ, Rudnitskaya A. Paralytic shellfish toxins (PST)-transforming enzymes: a review. Toxins (Basel) 2020; 12: 344. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 181.Rey V, Rossignoli AE, Rodríguez F, Blanco J, Garrido S, Ben-Gigirey B. Evaluation of the prevalence of paralytic shellfish toxins in non-traditional vectors and potential health risks associated to their consumption. Food Control 2025; 175: 111351. [Google Scholar]
- 182.Shumway SE. Phycotoxin-related shellfish poisoning: bivalve molluscs are not the only vectors. Rev Fish Sci 1995; 3: 1–31. [Google Scholar]
- 183.Deeds JR, Landsberg JH, Etheridge SM, Pitcher GC, Longan SW. Non-traditional vectors for paralytic shellfish poisoning. Mar Drugs 2008; 6: 308–48. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 184.Lefebvre KA, Quakenbush L, Frame E, et al. Prevalence of algal toxins in Alaskan marine mammals foraging in a changing arctic and subarctic environment. Harmful Algae 2016; 55: 13–24. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 185.Harley JR, Lanphier K, Kennedy EG, et al. The Southeast Alaska tribal ocean research (SEATOR) partnership: addressing data gaps in harmful algal bloom monitoring and shellfish safety in Southeast Alaska. Toxins (Basel) 2020; 12: 407. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 186.Van Hemert C, Harley JR, Baluss G, et al. Paralytic shellfish toxins associated with Arctic tern mortalities in Alaska. Harmful Algae 2022; 117: 102270. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 187.Lefebvre KA, Fachon E, Bowers EK, et al. Paralytic shellfish toxins in Alaskan Arctic food webs during the anomalously warm ocean conditions of 2019 and estimated toxin doses to Pacific walruses and bowhead whales. Harmful Algae 2022; 114: 102205. [DOI] [PubMed] [Google Scholar]
- 188.Pinardi N, Kumar TS, Alvarez-Fanjul E, et al. Ocean Decade Vision 2030 white papers - challenge 6: increase community resilience to ocean hazards. UNESCO-IOC, 2024. [Google Scholar]
- 189.Finch SC, Harwood DT. Past, current and future techniques for monitoring paralytic shellfish toxins in bivalve molluscs. Toxins (Basel) 2025; 17: 105. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 190.Bui QTN, Pradhan B, Kim HS, Ki JS. Environmental factors modulate saxitoxins (STXs) production in toxic dinoflagellate Alexandrium: an updated review of STXs and synthesis gene aspects. Toxins (Basel) 2024; 16: 210. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 191.Yuan KK, Li HY, Yang WD. Marine algal toxins and public health: insights from shellfish and fish, the main biological vectors. Mar Drugs 2024; 22: 510. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
